Kay Hagan Tick Reauthorization Act
Bill S 2398 ensures only patients and their direct healthcare providers access genetic test results, protecting privacy while limiting insurers to basic test notifications.
Bill S 2398 ensures only patients and their direct healthcare providers access genetic test results, protecting privacy while limiting insurers to basic test notifications.
Requires genetic testing results only be received by patients and health care providers providing direct care while health insurance companies only receive a record that the genetic testing was performed.
Bill S 2398 aims to enhance patient privacy and control over genetic testing results. The legislation seeks to ensure that only patients and their direct healthcare providers have access to the results of genetic tests, while health insurance companies will only receive a record indicating that the testing was conducted. This measure is intended to protect sensitive genetic information from being disclosed to third parties, thereby safeguarding patient confidentiality and promoting trust in genetic testing services.
Access to Results: The bill stipulates that genetic testing results can only be accessed by:
Insurance Company Notification: Health insurance companies will not receive detailed results of genetic tests. Instead, they will only be informed that a genetic test has been performed, without any specifics regarding the outcomes.
Bill S 2398 represents a significant step towards enhancing patient privacy regarding genetic testing. By limiting access to genetic test results, the bill aims to protect sensitive information from unauthorized disclosure, thereby fostering a more secure environment for patients undergoing genetic testing. The ongoing legislative process will determine the final outcome of this important measure.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.